PNC Financial Services Group’s Vincerx Pharma, Inc. Common Stock VINC Stock Holding History

PNC Financial Services Group’s Portfolio VINC Stock Details VINC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-500	Closed	-$13K	–	4644
2022 Q2	$13K	Hold	500	–	–	﹤0.01%	3701
2022 Q1	$40K	Hold	500	–	–	﹤0.01%	3235
2021 Q4	$102K	Hold	500	–	–	﹤0.01%	2683
2021 Q3	$162K	Hold	500	–	–	﹤0.01%	2328
2021 Q2	$130K	Hold	500	–	–	﹤0.01%	2503
2021 Q1	$193K	Buy	+500	New	+$202K	﹤0.01%	2191

Other funds holding VINC

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

SRC

Sage Rhino Capital Menlo Park, California $617M AUM 28.74% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

PNC Financial Services Group's VINC Position: Q3 2022 in Review

PNC Financial Services Group sold out of Vincerx Pharma, Inc. Common Stock (VINC) in Q3 2022, closing a stake of 500 shares — an estimated $13K sold.

PNC Financial Services Group first reported a position in VINC in Q1 2021 and held it in 6 quarters. The position peaked at $193K in Q1 2021. 42 funds tracked by Wall St. Rank hold VINC as of Q3 2022.

PNC Financial Services Group reported no remaining Vincerx Pharma, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
PNC Financial Services Group sold 500 Vincerx Pharma, Inc. Common Stock shares in Q3 2022, an estimated $13K.
PNC Financial Services Group first reported a position in Vincerx Pharma, Inc. Common Stock in Q1 2021 and held it in 6 quarters.
PNC Financial Services Group's Vincerx Pharma, Inc. Common Stock position peaked at $193K in Q1 2021.
42 funds tracked by Wall St. Rank held Vincerx Pharma, Inc. Common Stock as of Q3 2022.

Based on PNC Financial Services Group's 13F filing for Q3 2022, filed 10 Nov 2022.